TP53 and diffuse large B-cell lymphoma: Li et al. studied various clinicopathological aspects of anaplastic DLBCL and found that 86% of the cases were associated with a non-GCB immunophenotype and 51% of the cases had CD30 expression along with positive p53 staining in 80% of cases [3].